Indegene Ltd Share Price

Overview

Indegene Ltd share price is currently ₹563.23, up by ₹1.29 (0.23%) from its previous closing price of ₹561.94. The share price has gained 15.48% over the past month and declined -0.65% over the past year. The stock's 52-week low and high are ₹0.00 and ₹590.33, respectively. Indegene Ltd has a market capitalisation of ₹ 13,680.00 Cr. The share price was last updated on 24 Aug 2026, 03:30 PM IST.

Indegene Ltd

INDGN

₹0.00

₹1.29

0.23%

Healthcare

₹0.00(%)1D

Updated: 24 Aug 2026, 03:30:02 pm IST

Market Data

Open Price

₹561.68

Prev. Close

₹561.94

₹559.57

Day Low

₹565.55

Day High

₹0.00

52 Week Low

₹590.33

52 Week High

HealthcareBusiness Support

CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

33.75

Sector PE

42.03

PB Ratio

4.38

Sector PB

5.82

EPS

16.69

Dividend Yield

0.52

Today's Volume

275.289 K

5 Day Avg. Volume

471.667 K

PEG Ratio

-18.85

Market Cap.

₹ 13,680.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 112.5% at ₹2.25/Share	31-Jul-2026	31-Jul-2026
DividendsFinal Dividend of 100% at ₹2/Share	13-Jun-2025	13-Jun-2025

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
ICICI Prudential Technology Fund - Growth	18.65 Lac	18.65 Lac no change
SBI Innovative Opportunities Fund - Regular Plan - Growth	20.89 Lac	15.96 Lac (23.57%)
Sundaram Mid Cap Fund - Regular Plan - Growth	15.67 Lac	15.67 Lac no change
Sundaram Aggressive Hybrid Fund - Growth	9.67 Lac	10.37 Lac (7.23%)
ICICI Prudential Smallcap Fund - Growth	9.61 Lac	9.61 Lac no change

Show all holdings

About Indegene Ltd 👋

Indegene Limited is an India-based tech-native, life sciences commercialization company. The Company provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies. Its segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Brand Activation, and Others. The Enterprise Commercial Solutions business unit caters to the digital marketing operations of life sciences companies. The Enterprise Medical Solutions consolidates large-scale regulatory and medical operations for life sciences companies. The Brand Activation segment offers promotion of biopharmaceutical products and medical devices to HCPs for life sciences companies across channels. It provides customized marketing campaigns through a comprehensive portfolio of proprietary program offerings. Others mainly consist of consultancy and clinical business.